02-08-2019
vchal / Shutterstock.com
Tensions appear to be running high in the dispute between the Broad Institute of MIT and Harvard and the University of California, Berkeley (UC Berkeley) over which first invented the CRISPR gene-editing technology.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
PTAB, USPTO, CRISPR, Broad Institute, UC Berkeley, MIT, Harvard, Cas9, patent, genome editing
Harvard, 10x accuse NanoString of infringing gene sequencing tech
03-03-2022
UC Berkeley gets $54k for T-cell patent NFT
17-06-2021
UC Berkeley auctions Nobel Prize invention materials as NFTs
01-06-2021
UC Berkeley loses CRISPR patent at EPO
25-05-2021
Broad and ERS Genomics both claim victory in latest CRISPR ruling
14-09-2020
Sigma-Aldrich submits CRISPR petition at USPTO
23-07-2019
USPTO revives fight over CRISPR patents
27-06-2019
